We describe the clinical and pathologic findings in a murine model of mucopolysaccharidosis VII (Sly disease) that arose spontaneously in the C3H/HeOuJ mouse strain. Affected gus mps2J /gus mps2J mice are deficient in ␤-glucuronidase because of insertion of an intracisternal A particle element into intron 8 of the gus structural gene. This is the first model of a human lysosomal storage disease caused by an intracisternal A particle element insertion. Mice with the gus mps2J /gus mps2J genotype have Ͻ1% of normal ␤-glucuronidase activity and secondary elevations of other lysosomal enzymes. The phenotype includes shortened life-span, dysmorphic features, and skeletal dysplasia. Lysosomal storage of glycosaminoglycans is widespread and affects the brain, skeleton, eye, ear, heart valves, aorta, and the fixed tissue macrophage system. Thus the phenotypic and pathologic alterations in gus mps2J /gus mps2J mice are similar to those in patients with mucopolysaccharidosis VII. The finding of antibodies to ␤-glucuronidase in some older gus mps2J /gus mps2J mice suggests the mice produce sufficient enzyme to elicit an immune response. The gus mps2J /gus mps2J model provides another welldefined genetic system for the study of the pathophysiology of mucopolysaccharidosis and for evaluation of experimental therapies for lysosomal storage diseases. The MPSs are a group of LSDs characterized by a deficiency of a lysosomal acid hydrolase that degrades GAG. MPS patients with different enzyme deficiencies share clinical, pathologic, and biochemical features, including progressive lysosomal GAG accumulation and associated cellular and organ dysfunction. Premature death, mental retardation, coarse facies, and widespread skeletal and joint abnormalities, collectively referred to as dysostosis multiplex and hepatosplenomegaly, are seen in most patients with MPS (1). MPS VII (Sly disease) is characterized by GUSB (EC 3.2.1.31) deficiency and clinical and pathologic features similar to those seen in other types of MPS (1-3).
We describe the clinical and pathologic findings in a murine model of mucopolysaccharidosis VII (Sly disease) that arose spontaneously in the C3H/HeOuJ mouse strain. Affected gus mps2J /gus mps2J mice are deficient in ␤-glucuronidase because of insertion of an intracisternal A particle element into intron 8 of the gus structural gene. This is the first model of a human lysosomal storage disease caused by an intracisternal A particle element insertion. Mice with the gus mps2J /gus mps2J genotype have Ͻ1% of normal ␤-glucuronidase activity and secondary elevations of other lysosomal enzymes. The phenotype includes shortened life-span, dysmorphic features, and skeletal dysplasia. Lysosomal storage of glycosaminoglycans is widespread and affects the brain, skeleton, eye, ear, heart valves, aorta, and the fixed tissue macrophage system. Thus the phenotypic and pathologic alterations in gus mps2J /gus mps2J mice are similar to those in patients with mucopolysaccharidosis VII. The finding of antibodies to ␤-glucuronidase in some older gus mps2J /gus mps2J mice suggests the mice produce sufficient enzyme to elicit an immune response. The gus mps2J /gus mps2J model provides another welldefined genetic system for the study of the pathophysiology of mucopolysaccharidosis and for evaluation of experimental therapies for lysosomal storage diseases. The disease in gus mps2J / gus mps2J mice is less severe than that seen in the previously characterized B6.C-H2 The MPSs are a group of LSDs characterized by a deficiency of a lysosomal acid hydrolase that degrades GAG. MPS patients with different enzyme deficiencies share clinical, pathologic, and biochemical features, including progressive lysosomal GAG accumulation and associated cellular and organ dysfunction. Premature death, mental retardation, coarse facies, and widespread skeletal and joint abnormalities, collectively referred to as dysostosis multiplex and hepatosplenomegaly, are seen in most patients with MPS (1). MPS VII (Sly disease) is characterized by GUSB (EC 3.2.1.31) deficiency and clinical and pathologic features similar to those seen in other types of MPS (1) (2) (3) .
Effective therapies for patients with LSD are limited, and experiments on meaningful numbers of genetically identical mice with LSD can provide useful information on the effect of treatments for these disorders (4) . Animal models of LSD also allow detailed study of the pathophysiology of these disorders. Several spontaneously occurring models of MPS have been described and used to test therapies (1, 4) . The ideal model has clinical findings and pathology that resemble those of human LSD and is hardy enough to survive therapy. , in the GUSB structural gene, which results in Ͻ1% normal GUSB activity (5) . Affected offspring of the mouse have markedly reduced GUSB mRNA and secondary elevation of other lysosomal enzymes. The mutation is caused by a 5.4-kb IAP element insertion into intron 8 of the structural gene for GUSB on chromosome 5 (5). The IAP insertion correlates with a dramatic reduction in the amount of normal size gus mRNA and the presence of a truncated gus mRNA expressed at 5-to 7-fold less than normal (5) . This is the first LSD model caused by insertion of an IAP into the structural gene for a lysosomal enzyme. Murine IAPs are defective retrovirons encoded by a family of endogenous proviral elements; their transposition into genes can alter transcription.
The gus mps2J /gus mps2J mice have a progressive clinical course and pathologic features, including shortened life span, skeletal dysostosis, and widespread lysosomal storage with marked lysosomal distention in the fixed tissue macrophage system and skeleton. These clinical and pathologic findings parallel those of humans with MPS. The phenotype of the gus mps2J /gus mps2J mouse is similar to, although less severe than, that seen in a previously described model of murine MPS VII (6, 7) with a 1-bp deletion in exon 10 of the gus gene (8) .
METHODS
Clinical comparisons of C3H/HeOuJ-gus mps 2J /gus mps2J affected mice and phenotypically normal gus mps2J /ϩ mice maintained at The Jackson Laboratory were performed since 1992. All mice were handled with the highest standards of humane animal care. The Jackson Laboratory Animal Care and Use Committee approved the study we performed. This committee is the applicable institutional review board at The Jackson Laboratory. The Jackson Laboratory is fully accredited by the American Association for the Accreditation of Laboratory Animal Care. The gus mps2J /gus mps2J mice were identified by measuring GUSB levels in tail tissue. Eighteen male and 26 female gus mps2J /gus mps2J mice born before 1995 and six male and 19 females born after 1994 were followed to determine survival. Survival was compared using the t test. Groups of phenotypically normal gus mps2J /ϩ males (n ϭ 22) and females (n ϭ 7) and of gus mps2J /gus mps2J males (n ϭ 14) and females (n ϭ 14) were weighed at intervals from birth (0 d) to Ͼ1 mo of age.
Nineteen gus mps2J /gus mps2J and eight phenotypically normal mice from 1 to 19 mo old obtained before 1995 were killed by asphyxiation, and organs were sampled for histology. Tissue was fixed in 2% glutaraldehyde in 4% paraformaldehyde in PBS and postfixed in 1% osmium tetroxide. Samples of liver, spleen, kidney, skin, heart, aorta, bone and cartilage at the costochondral junction, and brain including hippocampus, parietal cortex and subcortical white matter, and cerebellum were prepared and studied by light or electron microscopy as previously described (7) .
The skeletons, including dissected long bones and skulls, were radiographed using a Faxitron Radiographic Analyzer. (Hewlett Packard, McMinnville, Oregon, U.S.A.) Images of forelimb bones of three normal and six gus mps2J /gus mps2J male adult mice were measured to evaluate long bone growth. The long bones from 3, 6, and 12 mo old mice were decalcified, routinely processed, and stained with hematoxylin and eosin and alcian blue-periodic acid-Schiff to identify tissue GAG histologically (7) . The external and middle ears from the same mice were dissected, fixed in 4% neutral buffered formalin, decalcified, and sectioned as previously described (9) .
Eighteen gus mps2J /gus mps2J mice Ͼ1 y (16 maintained by M.S.S., two maintained by E.H.B.) and eight gus mps2J /gus mps2J mice Յ1 y of age maintained by J.B. were evaluated using an ELISA technique as previously described (10) for antibodies to GUSB. Samples of intestine, brain, and liver of 16 of the mice Ͼ1 y of age were frozen, sectioned, and stained with a histochemical technique to demonstrate GUSB activity (10) .
RESULTS
The gus mps2J /gus mps2J mice were dysmorphic with growth retardation, a blunted facies, and short limbs (Fig. 1) . Dysmorphic features were readily apparent in weanling mice. Male gus mps2J /gus mps2J mice weights were similar to normal from 1 to 21 d of age. At weaning, the affected males tended to weigh less than normal, and as they aged, the difference in weight was Fig. 1 . A 1-y-old gus mps2J /gus mps2J mouse (right) is easily distinguished from its littermate (left) by its small size, short blunted nose, short limbs, and thick tail. 343 maintained (Fig. 2) . Females weighed less than males, and the affected females, like the affected males, weighed less than normal females after weaning. Average survival of 44 gus mps2J / gus mps2J mice born between 1992 and 1994 was 431 d (Fig. 3) . For 25 mice, all of the same gus mps2J /gus mps2J strain, but born between 1995 and 1997, average life-span was 187 d. Females were, on average, shorter lived than males.
Radiographic alterations in skeletons of gus mps2J /gus mps2J mice included wide oar-shaped ribs, a shortened wide pelvis, broad, short limbs, particularly proximal long bones, and a generalized increase in bone radiodensity (Fig. 4) . In adult gus mps2J /gus mps2J mice, the humerus was 85% of normal bone length and the radius-ulna, 94% of normal.
There was histologic evidence of lysosomal storage in all tissues examined, although the amount of storage varied from cell to cell and among mice. The fixed tissue macrophage system was affected with cytoplasmic vacuolization in Kupffer cells (Fig. 5A) , spleen, and bone marrow sinus-lining cells. Ultrastructurally, the vacuoles had a single membrane, and the stored material was fine fibrillogranular with associated large electron dense granules (Fig. 5B) . When the fibrillogranular material was lost in processing, vacuoles appeared empty. Hepatocytes did not have lysosomal storage. Spleen lymphocytes were only occasionally affected with a small amount of vacuolization.
Glomerular visceral and parietal epithelial cells and renal tubular epithelial cells had lysosomal distention. Skin storage was primarily in the dermal fibroblasts and in s.c. fat cells. The heart valves contained vacuolated stromal cells; scattered perivascular cells distended by vacuoles were seen in the myocardium, but myocytes contained no storage. Aortic medial and endothelial cells were distended by storage.
The ears of the gus mps2J /gus mps2J mice were markedly altered, showing changes similar to those previously described in the gus mps /gus mps MPS VII model (Fig. 6 ) (9). Several gus mps2J /gus mps2J mice had otitis media with associated thickening of the connective tissue of the middle ear mucosa. The tympanic membrane was thickened and ossicles were altered with vacuolization of chondrocytes and osteocytes and expansion of the osseous lacunae. Bone in other sites was also abnormal with marked lysosomal distention in osteoblasts, osteocytes, and chondrocytes (Fig. 7) . The synovium of large stifle joints was proliferated with marked stromal cell vacuolization and GAG accumulation.
The corneal fibroblasts in gus mps2J /gus mps2J mice had a moderate amount of cytoplasmic vacuolization, but retinal pigment epithelium had no lysosomal distention. Phenotypically normal mice of the C3H/HeOuJ strain, on which the gus mps2J mutation arose, have photoreceptor degeneration, a finding also seen in the gus mps2J /gus mps2J mice of this strain. In the CNS, lysosomal distention was seen in leptomeningeal, parenchymal perivascular, and glial cells and neocortical (Fig. 8A) and hippocampal (Fig. 8B ) cortex neurons. The amount of lysosomal storage in different neuronal groups Fig. 2 . The weight of MPS VII males (s) and females (}) tended to be less than that of phenotypically normal male (q) and female (') mice near weaning and thereafter. 4 . The skull of a 1-y-old gus mps2J /gus mps2J mouse (right) is shorter with thickened broad zygomatic arch and diffuse increase in radiodensity compared with an age-matched phenotypically normal mouse (left). The long bones are thickened, broad, and short in the gus mps2J /gus mps2J mouse (right) compared with the same bones in a normal mouse (left).
VOGLER ET AL.
varied among age-matched gus mps2J /gus mps2J mice and did not always correlate with the animal's age except in the hippocampus.
Before age 6 mo, the amount of storage throughout the hippocampus was sparse, without a clear gradient. After 6 mo, relative sparing of the pyramidal neurons in CA 1 sector of the hippocampal formation was apparent, but storage elsewhere in the hippocampus increased with age and was maximal at 1 y of age.
The cerebellar cortex Purkinje cells contained abundant electron-dense flocculent storage material (Fig. 8, C and D ) similar to that previously described in another MPS VII model (11) . Storage was not progressive after 3 mo of age. Meganeurites were prominent in the affected mice, appearing at 3 mo of age; they were most numerous in the oldest mice examined (14 and 19 mo of age) and occurred in both the hippocampal cortex and neocortex.
Seven (Fig. 3 ). An environmental change (e.g. handling, nutrition, infection) may have contributed to the recent change in survival of the gus The ultrastructural character of lysosomal GAG accumulation is similar in both MPS VII models, although, overall, lysosomal distention is less prominent in the gus mps2J /gus mps2J mice. The brain in the gus mps2J /gus mps2J mice has striking meganeurite formation, seen only occasionally in gus mps / gus mps mice (11) . Meganeurites are structural alterations of the neuronal axon hillock-initial axon segment and contain undegraded substrate. They are described in both human and animal LSD (11) and are thought to interfere with cell function by altering electrical properties of neurons (16) .
The relative lack of lysosomal storage in neurons in CA 1 of the hippocampus is similar to that seen in the gus mps /gus mps mice, and in humans with MPS VII and IV (11) . The variability in amount of storage in neuronal groups may reflect sitespecific differences in GUSB dependency for GAG turnover.
Unlike gus mps /gus mps MPS VII mice, gus mps2J /gus mps2J mice have no retinal pigment epithelium storage. This may be related to the photoreceptor loss characteristic of the C3H strain. Retinal pigment epithelium has a role in outer segment photoreceptor turnover, and without photoreceptors, GUSB deficiency may not result in GAG storage.
The phenotypic differences between the two inbred mouse strains, gus mps2J /gus mps2J and gus mps /gus mps , may be the result of genetic modifiers on the C3H background that modulate expression of GUSB deficiency in gus mps2J /gus mps2J mice. Wild-type C3H mice have only 10% to 38% of the GUSB activity seen in wild-type B6 mice (5) . The reduced GUSB activity may allow other pathways of GAG metabolism to develop in the C3H/HeOuJ mice, thus partially compensating for the marked reduction in GUSB. On the other hand, residual GUSB activity in the gus mps2J /gus mps2J mouse kidney is 0.5% the level found in the C3H/HeOuJϩ/ϩ mice compared with 0.005% of wild-type B6 levels in gus mps /gus mps mice. Possibly, the greater residual activity moderates consequences of the deficiency and contributes to the milder phenotype. Breeding the gus mps mutation onto the C3H/HeOuJ background (17) and the gus mps2J mutation onto the B6 background could help distinguish the contribution to enzyme deficiency and strainspecific modifying genes on the different phenotypes.
The appearance of GUSB antibody in some animals was an unexpected and very interesting finding. It raises the possibility that the gus mps2J gene presumably silenced by the IAP element insertion might be activated over time in some cells and produce enzyme that is recognized as foreign by the mouse, naïve to this antigen at birth. Consistent with this hypothesis is the observation by Gwynn et al. (5) that one of five gus mps2J / gus mps2J mice tested had an inexplicably high level of GUSB activity limited to the brain. What impact GUSB activity or antibodies to GUSB may have on survival of gus mps2J /gus mps2J mice requires further study. In long-term therapeutic studies using the gus mps2J /gus mps2J mice, evaluation of GUSB enzyme and antibody levels will be important.
Therapies for LSD in humans have included bone marrow transplantation and enzyme replacement (18) . Animal models Fig. 6 . A, ear of a 6-mo-old gus mps2J /gus mps2J mouse has laminated keratin in the external auditory canal (EC), a thick tympanic membrane, and otitis in the middle ear cavity (ME). B, same area of the EC and ME from a normal littermate is histologically normal. C, malleus (M) and incus (I) of the middle ear of a 3-mo-old gus mps2J /gus mps2J mouse has bone dysplasia similar to that seen in the other bones, with distention of osteocytes and chondrocytes by enlarged lysosomes and expansion of the lacunae. The ossicles are adhered to the adjacent middle ear mucosa. D, same ossicles from a phenotypically normal littermate have no alteration in the osteocytes or chondrocytes (hematoxylin and eosin; A, B: ϫ32; C, D: ϫ84). have provided useful information on potential therapies for LSD (1, 4) . The gus mps2J /gus mps2J mice offer several advantages in evaluating effects of various therapies. Because the gus mps2J /gus mps2J mice breed, larger numbers of MPS VII mice can be produced from matings of homozygous parents than of heterozygous matings. In addition, because all pups in gus mps2J /gus mps2J matings are MPS VII (rather than one in four in the gus mps /ϩ matings), it is much easier to test the efficacy of in utero therapies such as enzyme replacement, stem cell transplantation, and gene therapy on MPS VII fetuses. Because pathologic alterations in LSD are already present in newborn mice (7), the most effective treatment for LSD may require initiation of therapy in utero. This report provides clinical and pathologic information that will be a useful benchmark for evaluation of such therapeutic strategies in the gus mps2J / gus mps2J mouse. 
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